Sienna Biopharmaceuticals Inc (SNNAQ)
0.00
USD |
OTCM |
May 16, 16:00
Sienna Biopharmaceuticals Shareholders Equity (Quarterly): 23.10M for Sept. 30, 2019
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 23.10M |
| June 30, 2019 | 26.98M |
| March 31, 2019 | 33.29M |
| December 31, 2018 | 26.58M |
| September 30, 2018 | 44.93M |
| June 30, 2018 | 55.53M |
| Date | Value |
|---|---|
| March 31, 2018 | 76.42M |
| December 31, 2017 | 91.20M |
| September 30, 2017 | 96.40M |
| June 30, 2017 | 44.00M |
| March 31, 2017 | 13.56M |
| December 31, 2016 | 22.12M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
23.10M
Minimum
Sep 2019
26.98M
Maximum
Jun 2019
25.04M
Average
25.04M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.49M |
| Total Liabilities (Quarterly) | 20.39M |